Article

How Many Opioids Have Received ADP Designation on the Basis of Category 1 Studies Alone?

Conference|PAINWeek Conference

J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.

J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.

Related Videos
Related Content
Sickle cell anemia: painful crises, anemia, infections. Treatment focuses on managing symptoms and preventing complications.
April 26th 2025

Hydroxyurea Produces Long-Term Clinical Benefits in Pediatrics With Sickle Cell Anemia

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Research Shows Diabetes Rewires the Brain, Mimicking Early Alzheimer Disease
April 25th 2025

Research Shows Diabetes Rewires the Brain, Mimicking Early Alzheimer Disease

Aislinn Antrim, Managing Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Health care professional preparing injection -- Image credit: BajimBa | stock.adobe.com
April 25th 2025

The Benefits and Challenges of Subcutaneous Injection in Cancer Care

Alexandra Gerlach, Associate Editor
Endometriosis diagnosis -- Image credit: H_Ko | stock.adobe.com
April 25th 2025

Survey Respondents Report Dietary Modifications Help Relieve Endometriosis-Related Pain

Gillian McGovern, Associate Editor